4 February
2025
FILTRONIC
PLC
("Filtronic", the "Company" or the "Group")
HALF YEAR RESULTS FOR THE SIX
MONTHS ENDED 30 NOVEMBER
2024
Filtronic plc (AIM: FTC), the
designer and manufacturer of products and sub-systems for the
aerospace, defence, telecoms infrastructure, space and critical
communications markets, announces its half year results for the six
months ended 30 November 2024 ("H1
2025").
Financial Highlights
|
H1 2025
|
H1
2024
|
Revenue
|
£25.6m
|
£8.5m
|
Adjusted EBITDA¹
|
£8.7m
|
£0.2m
|
Operating profit/(loss)
|
£6.8m
|
(£0.4m)
|
Profit/(loss) for the
period
|
£6.7m
|
(£0.5m)
|
Basic earnings/(loss) per
share
|
3.08p
|
(0.24p)
|
Diluted earnings/(loss) per
share
|
3.04p
|
(0.24p)
|
Cash generated from operating
activities
|
£2.1m
|
£1.8m
|
|
|
|
|
At 30 Nov
2024
|
At 31 May
2024
|
Net cash when including right of use
property leases
|
£4.3m
|
£4.2m
|
Net cash when excluding right of use
property leases
|
£5.1m
|
£5.2m
|
|
|
|
|
|
|
¹
Adjusted EBITDA is earnings before interest, taxation,
depreciation, amortisation, share-based payments and exceptional
items.
Operational Highlights
· Strong order inflow from SpaceX in the period aligned with the
Strategic Partnership agreement.
· Technology developments progressing well to deliver on our
future product roadmap in conjunction with key
customers.
· Excellent progress made with the recruitment drive to scale
the engineering team to meet demand and serve the healthy
opportunity pipeline. This has resulted in a 16% headcount increase
including the recruitment of a design team in Cambridge.
· Two new production lines installed in the period to increase
manufacturing capacity to support revenue growth.
· Healthy cash position enables continued investment in revenue
growth initiatives to deliver the strategic plan.
Post-period Highlights
· Leadership team further strengthened with three key
appointments added.
· Positive cadence of order intake has continued in H2 resulting
in two material upgrades to market expectations in the last two
months.
Commenting, Jonathan Neale,
Chairman, said: "We are pleased to
communicate these strong set of interim results. Robust order
intake has resulted in the improved revenue and profit outlook in
H2 which we communicated in market upgrades in December 2024 and
January 2025. Investing in the business to underpin the orderbook
has been timely and effective and we look forward to being able to
communicate more about the next financial year as things develop
during H2".
Enquiries
Filtronic plc
|
www.filtronic.com
|
Nat Edington, CEO
|
01740 618800 or
investor.relations@filtronic.com
|
Michael Tyerman, CFO
|
|
|
|
Cavendish Capital Markets Limited
|
020 7220 0500
|
Jonny Franklin-Adams/Isaac
Hooper/Trisyia Jamaludin (Corporate Finance)
|
Sunila de Silva (ECM)
|
|
|
Walbrook PR Limited
|
020 7933 8780 or
filtronic@walbrookpr.com
|
Nick Rome/Joseph Walker
|
|
Notes:
This announcement contains inside
information for the purposes of Article 7 of Regulation (EU) No
596/2014.
Forward-looking
statements
Certain statements in this
half-yearly financial report are forward-looking. Where the
half-yearly financial report includes forward-looking statements,
these are made by the directors in good faith based on the
information available to them at the time of their approval of this
report. Such statements are based on current expectations and are
subject to a number of risks and uncertainties, including both
economic and business risk factors that could cause actual events
or results to differ materially from any expected future events or
results referred to in these forward-looking statements. Unless
otherwise required by applicable law, regulation or accounting
standard, the Group undertakes no obligation to update any
forward-looking statements whether as a result of new information,
future events or otherwise.
Chairman's Statement
I am pleased to present the half
year results for FY2025 and update shareholders on the progress we
have made in the period. This is not only reflected in the
financial results, but also the great strides we have made to
develop the organisation and appropriately scale the
business.
Engineering recruitment has been
more successful, with a significant uplift in headcount, following
the opening of a new design centre in Cambridge coupled with a
re-energised recruitment strategy. To meet the growing demand, we
have strengthened our leadership team not just in technical areas,
but also in operations, engineering, commercial and business
development.
We have an exciting technology
roadmap, developing semiconductor and passive technologies in the
millimetre-wave spectrum for both the ground station, payload and
platform systems and components. These are supported by leading
edge global semiconductor foundry technologies. The developments
relating to these are progressing well and we still expect to
deliver against critical timelines.
We continue our aim to deliver
increased output from our existing operational facilities and
production resources. To meet the strong demand, we successfully
introduced two new production lines during the period to give
further flexibility and enable further conversion of new business.
As we move to larger premises at our headquarters in Sedgefield,
County Durham, later this year we expect to see further gains to
capacity and efficiency.
Financial Performance Summary
The Board are pleased with the
trading results in H1. Coupled with this, strong order intake
resulted in the improved revenue and profit outlook in H2 which we
communicated in December and January.
Group revenue for the first half of
FY2025 increased by over 200% on the prior year with sales of
£25.6m (H1 2024: £8.5m).
We have invested further in the
business during the period to support the growth, leading to our
overhead cost base increasing by 62%. Despite this, the revenue
growth from increased trading has delivered an operating profit of
£6.8m (H1 2024: operating loss of £0.4m) and adjusted earnings
before interest, taxation, depreciation and amortisation ("adjusted
EBITDA") of £8.7m (H1 2024: £0.2m).
At 30 November 2024, the Group
recorded cash in the bank of £7.2m (31 May 2024: £7.2m), net cash
of £5.1m when excluding the right of use property leases (31 May
2024: £5.2m) and net cash including right of use property leases of
£4.3m (31 May 2024: £4.2m).
Our
Markets
The Low Earth Orbit ("LEO") space
market remains a driving force for the business with the market
still offering further significant growth potential.
Our strategic partnership with the
market leader, SpaceX, continues to strengthen and grow. The
success of the relationship has enabled us to deliver at high
volume and high quality, working closely with our business and
supply chain partners. This achievement has enabled both parties to
consider further collaboration following the remarkable success of
the Starlink constellation.
We still see LEO space payload as an
exciting area for us and we have factored that into our technology
road map. As a lead-in project to payload, we have a prestigious
programme underway with the European Space Agency ("ESA") which is
expected to complete over the next year with material revenues
still to be recognised in FY2026.
We were delighted to see our
customers, Almagest Space Corporation and XDLINX Space Labs, take
our first mmWave product into space on their recently developed
satellite using one of our Morpheus X2 E-band
transceivers.
The defence pipeline contains
several interesting opportunities particularly within airborne
radar systems. Our active programmes, with QinetiQ will
substantively complete in FY2025, and with BAE Maritime Systems
within FY2026. The UK government's Strategic Defence Review pushed
back the planned timing of a number of prospective opportunities
but has not impacted financial forecasts.
We are pleased to see the UK
Government secure the future of the semiconductor foundry at Newton
Aycliffe, County Durham, safeguarding critical semiconductor
components for the UK defence market and providing longevity of
supply. This creates an opportunity for us to align ourselves with
the Defence Industrial Strategy where we can utilise our advanced
semiconductor packaging and test capability which we see as
essential for sovereign capability and competitiveness.
Outlook
The Group has continued the momentum
from H1 with a strong start to trading in H2. Our order book is
healthy and underpins the recent upgrades, whilst the opportunity
pipeline continues to build serving us well as we move towards the
next financial year.
The overall macro factors for the
low earth orbit ("LEO") satellite market are robust, driven by the
emergence of reusable launch vehicles and advanced manufacturing,
which significantly reduces the cost of launch and enables more
companies to participate in space activities. Commercial
engagements, not only with SpaceX, have demonstrated to us the
relevance of our technology to the wider satellite market serving a
multitude of missions. This enables us to bring forwards
leading-edge high-performance technology that we anticipate could
be widely adopted.
The industry growth rates for LEO
satellite market are projected to grow at a CAGR of over 9% by 2031
with the overall market size growing to $310bn USD by 2031
(Exactitude Consultancy)
whilst the defence market for electronic warfare is expected to
grow to 2031 by 7% to $35bn USD (Insight Partners).
I am grateful for the hard work and
dedication of the entire Filtronic team and
our impressive supply chain partners in their efforts to achieve
considerable production volume ramps at the quality that premium
markets expect. I would like to take this opportunity to publicly
thank them all for their innovation, commitment and
success.
Jonathan Neale
Chairman, 3 February
2025
Condensed Consolidated Interim Income
Statement
For
the period ended 30 November 2024
|
|
6 months
|
6
months
|
Year
|
|
|
|
Ended
|
Ended
|
Ended
|
|
|
|
30 November
|
30
November
|
31
May
|
|
|
|
2024
|
2023
|
2024
|
|
|
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
|
Continuing operations
|
Note
|
£000
|
£000
|
£000
|
|
|
|
|
|
|
|
Revenue
|
5
|
25,595
|
8,480
|
25,432
|
|
|
|
======
|
======
|
======
|
|
|
|
|
|
|
|
Adjusted EBITDA¹
|
|
8,712
|
206
|
4,889
|
|
Depreciation of property, plant and
equipment and right of use assets
|
|
(607)
|
(451)
|
(945)
|
|
Amortisation of intangible
assets
|
|
(258)
|
(124)
|
(287)
|
|
Amortisation of contract
assets
|
10
|
(901)
|
-
|
-
|
|
Share-based payments
|
|
(185)
|
-
|
(47)
|
|
|
|
----------
|
----------
|
----------
|
|
Operating profit/(loss)
|
6
|
6,761
|
(369)
|
3,610
|
|
|
|
|
|
|
|
Finance costs
|
7
|
(127)
|
(166)
|
(332)
|
|
Finance income
|
8
|
101
|
18
|
83
|
|
|
|
----------
|
----------
|
----------
|
|
Profit/(loss) before taxation
|
|
6,735
|
(517)
|
3,361
|
|
Taxation
|
|
(7)
|
(5)
|
(220)
|
|
|
|
----------
|
----------
|
----------
|
|
Profit/(loss) for the period
|
|
6,728
|
(522)
|
3,141
|
|
|
|
======
|
======
|
======
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings/(loss) per share
(pence)
|
|
|
|
|
|
|
|
|
|
Basic earnings/(loss) per
share
|
9
|
3.08p
|
(0.24p)
|
1.45p
|
|
Diluted earnings/(loss) per
share
|
9
|
3.04p
|
(0.24p)
|
1.41p
|
|
|
|
|
|
|
|
|
|
======
|
======
|
======
|
1
Adjusted EBITDA is defined as profit before interest,
taxation, depreciation, amortization, share-based payments and
exceptional items which is a non-GAAP metric used by management and
is not an IFRS disclosure.
Condensed Consolidated Interim
Statement of Comprehensive Income
For
the period ended 30 November 2024
|
6 months
|
6
months
|
Year
|
|
Ended
|
Ended
|
Ended
|
|
30 November
|
30
November
|
31
May
|
|
2024
|
2023
|
2024
|
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
|
£000
|
£000
|
£000
|
|
|
|
|
Profit/(loss) for the period
|
6,728
|
(522)
|
3,141
|
|
----------
|
----------
|
----------
|
Items that are or may be subsequently reclassified to profit
and loss:
|
|
|
|
Currency translation arising on
consolidation
|
(15)
|
(39)
|
(52)
|
|
----------
|
----------
|
----------
|
Total comprehensive income/(expense) for the
period
|
6,713
|
(561)
|
3,089
|
|
======
|
======
|
======
|
The total comprehensive
income/(expense) for the period is attributable to the equity
shareholders of the parent company Filtronic plc.
Condensed Consolidated Interim
Statement of Financial Position
At
30 November 2024
|
|
|
|
(restated)
|
|
Note
|
30 November
|
30 November
|
31
May
|
|
|
2024
|
2023
|
2024
|
|
|
(Unaudited)
|
(Unaudited)
|
(Audited*)
|
|
|
£000
|
£000
|
£000
|
Non-current assets
|
|
|
|
|
Goodwill and other intangible
assets
|
|
2,604
|
1,977
|
2,271
|
Right of use assets
|
|
3,774
|
3,566
|
3,756
|
Property, plant and
equipment
|
|
2,061
|
764
|
1,153
|
Contract assets
|
10
|
1,302
|
-
|
1,302
|
Deferred tax
|
|
1,046
|
1,252
|
1,047
|
|
|
----------
|
----------
|
----------
|
|
|
10,787
|
7,559
|
9,529
|
|
|
----------
|
----------
|
----------
|
Current assets
|
|
|
|
|
Inventories
|
|
4,202
|
2,569
|
3,273
|
Trade and other
receivables
|
|
15,070
|
4,545
|
6,550
|
Contract assets
|
10
|
401
|
-
|
1,303
|
Cash and cash equivalents
|
|
7,204
|
4,057
|
7,215
|
|
|
----------
|
----------
|
----------
|
|
|
26,877
|
11,171
|
18,341
|
|
|
----------
|
----------
|
----------
|
|
|
|
|
|
|
|
----------
|
----------
|
----------
|
Total assets
|
|
37,664
|
18,730
|
27,870
|
|
|
----------
|
----------
|
----------
|
Current liabilities
|
|
|
|
|
Trade and other payables
|
|
8,224
|
2,759
|
5,406
|
Provisions
|
|
493
|
363
|
493
|
Deferred Income
|
11
|
1,426
|
1,235
|
1,403
|
Lease liabilities
|
|
731
|
746
|
895
|
|
|
----------
|
----------
|
----------
|
|
|
10,874
|
5,103
|
8,197
|
|
|
----------
|
----------
|
----------
|
Long term liabilities
|
|
|
|
|
Deferred income
|
11
|
116
|
537
|
132
|
Lease liabilities
|
|
2,214
|
2,092
|
2,121
|
|
|
----------
|
----------
|
----------
|
|
|
2,330
|
2,629
|
2,253
|
|
|
----------
|
----------
|
----------
|
|
|
|
|
|
|
|
----------
|
----------
|
----------
|
Total liabilities
|
|
13,204
|
7,732
|
10,450
|
|
|
----------
|
----------
|
----------
|
|
|
|
|
|
|
|
----------
|
----------
|
----------
|
Net
assets
|
|
24,460
|
10,998
|
17,420
|
|
|
======
|
======
|
======
|
Equity
|
|
|
|
|
Share capital
|
12
|
10,800
|
10,796
|
10,798
|
Share premium
|
13
|
11,352
|
11,087
|
11,213
|
Share warrant reserve
|
10
|
2,605
|
-
|
2,605
|
Translation reserve
|
|
(537)
|
(509)
|
(522)
|
Retained earnings
|
|
240
|
(10,376)
|
(6,674)
|
|
|
----------
|
----------
|
----------
|
Total equity
|
|
24,460
|
10,998
|
17,420
|
|
|
======
|
======
|
======
|
|
|
|
|
|
The total equity is attributable to
the equity shareholders of the parent company Filtronic
plc.
Company number 2891064
* Certain prior period figures are
restated, please refer to note 15 for further
information.
Condensed Consolidated Interim
Statement of Changes in Equity
For
the period ended 30 November 2024
|
|
|
|
|
|
|
|
Share
capital
|
Share
premium
|
Share warrant
reserve
|
Translation
reserve
|
Retained
earnings
|
Total
equity
|
|
£000
|
£000
|
£000
|
£000
|
£000
|
£000
|
|
|
|
|
|
|
|
Balance at 30 November
2023
|
10,796
|
11,087
|
-
|
(509)
|
(10,376)
|
10,998
|
Profit for the period
|
-
|
-
|
-
|
-
|
3,663
|
3,663
|
New shares issued (net of issue
costs)
|
2
|
126
|
-
|
-
|
-
|
128
|
Share warrants
|
-
|
-
|
2,605
|
|
|
2,605
|
Currency translation movement
arising on consolidation
|
-
|
-
|
-
|
(13)
|
-
|
(13)
|
Share-based payments
|
-
|
-
|
-
|
-
|
39
|
39
|
|
----------
|
----------
|
----------
|
----------
|
----------
|
----------
|
Balance at 31 May 2024
(restated*)
|
10,798
|
11,213
|
2,605
|
(522)
|
(6,674)
|
17,420
|
Profit for the period
|
-
|
-
|
-
|
-
|
6,728
|
6,728
|
New shares issued (net of issue
costs)
|
2
|
139
|
-
|
-
|
-
|
141
|
Currency translation movement
arising on consolidation
|
-
|
-
|
-
|
(15)
|
-
|
(15)
|
Share-based payments
|
-
|
-
|
-
|
-
|
186
|
186
|
|
----------
|
----------
|
----------
|
----------
|
----------
|
----------
|
Balance at 30 November 2024
|
10,800
|
11,352
|
2,605
|
(537)
|
240
|
24,460
|
|
======
|
======
|
======
|
======
|
======
|
======
|
|
|
|
|
|
|
|
* Certain prior period figures are restated, please refer
to note 15 for further information.
Condensed Consolidated Interim Cash
Flow Statement
For
the period ended 30 November 2024
|
|
6 months
|
6
months
|
Year
|
|
|
Ended
|
Ended
|
Ended
|
|
|
30 November
|
30
November
|
31
May
|
|
|
2024
|
2023
|
2024
|
|
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
|
|
£000
|
£000
|
£000
|
Cash
flows from operating activities
|
|
|
|
|
Profit/(loss) for the
period
|
|
6,728
|
(522)
|
3,141
|
Taxation
|
|
7
|
5
|
220
|
Finance income
|
|
(101)
|
(18)
|
(83)
|
Finance costs
|
|
127
|
166
|
332
|
|
|
----------
|
----------
|
----------
|
Operating profit/(loss)
|
|
6,761
|
(369)
|
3,610
|
Tax paid
|
|
(7)
|
(5)
|
(16)
|
Share-based payments
|
|
186
|
8
|
47
|
Depreciation
|
|
607
|
451
|
945
|
Amortisation of contract
assets
|
|
901
|
-
|
-
|
Amortisation of intangible
assets
|
|
258
|
124
|
287
|
Movement in inventories
|
|
(926)
|
186
|
(531)
|
Movement in trade and other
receivables
|
|
(8,534)
|
766
|
(1,235)
|
Movement in trade and other
payables
|
|
2,820
|
(906)
|
1,749
|
Movement in provisions
|
|
-
|
(1)
|
129
|
Change in deferred income
|
|
8
|
1,579
|
1,342
|
|
|
----------
|
----------
|
----------
|
Net
cash generated from operating activities
|
|
2,074
|
1,833
|
6,327
|
|
|
----------
|
----------
|
----------
|
Cash
flows from investing activities
|
|
|
|
|
Capitalisation of development
costs
|
|
(486)
|
(326)
|
(677)
|
Acquisition of intangible
assets
|
|
(103)
|
-
|
(107)
|
Acquisition of plant and
equipment
|
|
(1,535)
|
(162)
|
(666)
|
Acquisition of right of use
assets
|
|
-
|
(34)
|
(120)
|
Interest received
|
|
101
|
14
|
83
|
|
|
----------
|
----------
|
----------
|
Net
cash used in investing activities
|
|
(2,023)
|
(508)
|
(1,487)
|
|
|
----------
|
----------
|
----------
|
Cash
flows from financing activities
|
|
|
|
|
Interest paid
|
|
(127)
|
(166)
|
(332)
|
Proceeds from financing
agreements
|
|
-
|
-
|
750
|
Exercise of employee share
options
|
|
141
|
10
|
138
|
Repayment of principal element of
lease liabilities
|
|
(437)
|
(411)
|
(784)
|
Receipt of interest-bearing
borrowings
|
|
364
|
684
|
-
|
|
|
----------
|
----------
|
----------
|
Net
cash generated (used in)/from financing
activities
|
|
(59)
|
117
|
(228)
|
|
|
----------
|
----------
|
----------
|
Movement in cash and cash equivalents
|
|
(8)
|
1,442
|
4,612
|
Currency exchange
movements
|
|
(3)
|
5
|
(7)
|
Opening cash and cash
equivalents
|
|
7,215
|
2,610
|
2,610
|
|
|
----------
|
----------
|
----------
|
Closing cash and cash equivalents
|
|
7,204
|
4,057
|
7,215
|
|
|
======
|
======
|
======
|
Notes to the Condensed Financial
Statements
1 Company
information
Filtronic plc is a company registered and domiciled in
the United Kingdom and is listed on the AIM market of the London
Stock Exchange. The Company's registered number is 2891064. The
address of the Company's registered office is Filtronic plc, Plexus
1, NETPark, Thomas Wright Way, Sedgefield, County Durham, TS21
3FD.
Copies of the Company's Annual Report and interim financial
report are available from the Company's registered office or the
Company's website at www.filtronic.com.
2 Basis of preparation
Whilst the financial information included in this
preliminary statement has been prepared on the basis of the
requirements of IFRSs in issue, this statement does not itself
contain sufficient information to comply with IFRS.
These financial results for the six months ended 30
November 2024 do not comprise statutory accounts within the meaning
of Section 434 of the Companies Act 2006. The interim report should
be read in conjunction with the Annual Report 2024, which includes
annual financial statements for the year ended 31 May 2024. Those
accounts have been reported on by the Company's auditor and
delivered to the registrar of companies. The report of the auditor
was (i) unqualified (ii) did not include a reference to any matters
to which the auditor drew attention by way of emphasis without
qualifying their report, and (iii) did not contain a statement
under section 498 (2) or (3) of the Companies Act 2006.
The condensed consolidated financial statements for
the six months ended 30 November 2024 consolidate the financial
statements of the Company and all of its subsidiaries (together
referred to as the "Group"). Transactions between Group companies,
which are related parties, have been eliminated upon consolidation
and therefore do not require disclosure.
The condensed consolidated financial statements for
the six months ended 30 November 2024 and comparative period have
not been audited. The interim financial report for the six months
ended 30 November 2024 was approved by the Board on 3 February
2025.
3 Going Concern
In
accordance with corporate governance requirements the directors
have undertaken a review of forecasts and the Group's cash
requirements to consider whether it is appropriate that the Group
continues to adopt the going concern assumption.
The
directors have reviewed the projected cash flow and other relevant
information, including a 'severe but plausible' scenario and have a
reasonable expectation that the Group has adequate resources to
continue in operational existence and therefore it remains
appropriate to adopt the going concern basis in preparing the
interim financial report for the six months ended 30 November
2024.
4
Accounting estimates and judgements
The preparation of the financial statements requires the use
of accounting estimates and judgements that affect the application
of accounting policies and reported amounts of assets and
liabilities, income and expenses. The accounting estimates and
judgements are continually evaluated and are based on historical
experience and other factors, including expectations of the future
that are believed to be reasonable under the circumstances. Actual
results may differ from the expected results. Revisions to
accounting estimates are recognised in the period in which the
estimate is revised if the revision affects only that period, or in
the period of the revision and future periods if the revision
affects both current and future periods. The accounting estimates
and judgements that have a significant effect on the financial
statements are considered in the Filtronic plc Annual Report for
the year ended 31 May 2024 which can be found on the Filtronic
website. Unless stated below there is no material change to those
judgements from the Annual Report in the basis of
calculation.
There
is one change to the accounting estimates and judgements in the
period relating to the share warrants issued to SpaceX. This
judgement is described in note 10.
5
Segmental
Analysis
Operating Segments
IFRS 8 requires consideration of the identity of
the Chief Operating Decision Maker
('CODM') within the Group. In line with the
Group's internal reporting framework and management structure, the
key strategic and operating decisions are made by the Board, who
reviews internal monthly management reports, budget and forecast
information as part of this. Accordingly, the Board is deemed to be
the CODM.
The CODM has identified one operating segment within
the Group as defined under IFRS 8. In turn, this is the only
reportable segment of the Group as the entities in the Group have
similar products and services, production processes and economic
characteristics. Therefore, there is no allocation of operating
expenses, profit measures or assets and liabilities to specific
commercial markets.
Accordingly, the CODM assesses the performance of the
operating segment on financial information which is measured and
presented in a manner consistent with those in the financial
statements by reference to Group results against budget.
The
Group profit measures are adjusted operating profit and adjusted
EBITDA, both disclosed on the face of the consolidated income
statement. No differences exist between the basis of preparation of
the performance measures used by management and the figures in the
Group financial statements.
Revenue by Destination
The revenue presented is based on
the geographic location of customers receiving the product/service
from the continuing operations.
|
6 months
|
6
months
|
Year
|
|
Ended
|
Ended
|
Ended
|
|
30 November
|
30
November
|
31
May
|
|
2024
|
2023
|
2024
|
|
£000
|
£000
|
£000
|
Revenue
|
|
|
|
United
Kingdom
|
1,559
|
1,396
|
2,239
|
Europe
|
508
|
1,046
|
2,154
|
Americas
|
23,446
|
3,433
|
17,121
|
Rest of the
world
|
82
|
2,605
|
3,918
|
|
----------
|
----------
|
----------
|
|
25,595
|
8,480
|
25,432
|
|
======
|
======
|
======
|
Revenue from sales
The revenue presented is based on
the Group deriving revenue from product sales and those received
from Non-Recurring Engineering ("NRE") at a point in time when the
performance obligation is satisfied.
|
6 months
|
6
months
|
Year
|
|
Ended
|
Ended
|
Ended
|
|
30 November
|
30
November
|
31
May
|
|
2024
|
2023
|
2024
|
|
£000
|
£000
|
£000
|
Revenue
|
|
|
|
Sales of
product
|
25,565
|
8,031
|
24,135
|
NRE - point in
time
|
931
|
449
|
1,297
|
Amortisation of
contract assets
|
(901)
|
-
|
-
|
|
----------
|
----------
|
----------
|
|
25,595
|
8,480
|
25,432
|
|
======
|
======
|
======
|
6 Operating profit/(loss)
|
6 months
|
6
months
|
Year
|
|
Ended
|
Ended
|
Ended
|
|
30 November
|
30
November
|
31
May
|
|
2024
|
2023
|
2024
|
|
£000
|
£000
|
£000
|
|
|
|
|
Revenue
|
25,595
|
8,480
|
25,432
|
|
----------
|
----------
|
----------
|
Material cost of goods sold
|
9,738
|
3,245
|
9,357
|
|
|
|
|
Wages and
salaries
|
4,187
|
3,171
|
6,092
|
Social security costs
|
469
|
316
|
650
|
Pension costs
|
269
|
182
|
372
|
Bonus
|
540
|
-
|
810
|
Temporary employees
|
418
|
-
|
208
|
Share-based payments
|
186
|
8
|
47
|
|
----------
|
----------
|
----------
|
Employee costs
|
6,069
|
3,677
|
8,179
|
|
----------
|
----------
|
----------
|
Amortisation of intangible
assets
|
258
|
124
|
287
|
Depreciation of property, plant and
equipment and right of use assets
|
607
|
451
|
945
|
|
----------
|
----------
|
----------
|
Depreciation and
amortisation
|
865
|
575
|
1,232
|
|
----------
|
----------
|
----------
|
Other operating income
|
(34)
|
(153)
|
(326)
|
Other expenses
|
2196
|
1,505
|
3,380
|
|
----------
|
----------
|
----------
|
Total operating costs
|
9,096
|
5,604
|
12,465
|
|
======
|
======
|
======
|
Operating profit/(loss)
|
6,761
|
(369)
|
3,610
|
|
======
|
======
|
======
|
Development costs of £486,000 were
capitalised in HY2025 (HY2024: £295,000).
Other operating income relates to
grants received for plant and machinery and R&D innovation
whilst R&D tax credits claimed under the RDEC scheme are also
recognised in operating profit.
7 Finance costs
|
6 months
|
6
months
|
Year
|
|
Ended
|
Ended
|
Ended
|
|
30 November
|
30
November
|
31
May
|
|
2024
|
2023
|
2024
|
|
£000
|
£000
|
£000
|
|
|
|
|
Interest expense for lease
arrangements
|
127
|
114
|
236
|
Minimum service costs and interest
charges on invoice discounting facilities
|
-
|
52
|
96
|
|
----------
|
----------
|
----------
|
|
127
|
166
|
332
|
|
======
|
======
|
======
|
|
|
|
|
8
Finance income
|
6 months
|
6
months
|
Year
|
|
Ended
|
Ended
|
Ended
|
|
30 November
|
30
November
|
31
May
|
|
2024
|
2023
|
2024
|
|
£000
|
£000
|
£000
|
|
|
|
|
Revaluation of foreign currency
denominated intercompany balance
|
9
|
4
|
1
|
Interest receipt on treasury
deposits
|
92
|
14
|
82
|
|
----------
|
----------
|
----------
|
|
101
|
18
|
83
|
|
======
|
======
|
======
|
|
|
|
|
9
Basic and diluted earnings/(loss) per
share
|
6 months
|
6
months
|
Year
|
|
Ended
|
Ended
|
Ended
|
|
30 November
|
30
November
|
31
May
|
|
2024
|
2023
|
2024
|
|
£000
|
£000
|
£000
|
|
|
|
|
Profit/(loss) for the
period
|
6,728
|
(522)
|
3,141
|
|
======
|
======
|
======
|
|
|
|
|
|
'000
|
'000
|
'000
|
Basic weighted
average number of shares
|
218,771
|
215,172
|
216,340
|
Dilution effect of share
options
|
2,663
|
2,781
|
6,555
|
|
-----------
|
-----------
|
----------
|
Diluted weighted average number of
shares
|
221,434
|
217,953
|
222,895
|
|
=======
|
=======
|
======
|
|
|
|
|
Basic earnings/(loss) per share (pence)
|
|
3.08p
|
(0.24p)
|
1.45p
|
|
|
|
|
|
Diluted
earnings/(loss) per share (pence)
|
|
3.04p
|
(0.24p)
|
1.41p
|
|
|
======
|
======
|
======
|
|
|
|
|
| |
10 SpaceX share warrants
On 24 April 2024, the Group entered
into a share warrant arrangement with SpaceX in conjunction with a
commercial agreement and strategic partnership. This related to the
supply of E-band Solid State Power Amplifiers ("SSPAs") and new
technology being developed for SpaceX for use in their Starlink
constellation. Full details of the warrants can be found in the
2024 Annual Report and Accounts in note 31.
The warrant agreement grants SpaceX
the right to acquire up to 21,712,109 shares of the Company
(equivalent to 10% of the Company's total share capital at the
inception of the warrant agreement). The exercise price of vested
warrants is 33.0p per share, based on the closing mid-market price
at 23 April 2024, which is the date prior to signing the warrant
agreement. The directors have assessed the warrants and have made a
judgement that the warrants should be treated as equity instruments
as defined by IAS32. This is because the warrants have a fixed
consideration at 33.0p per share for a fixed number of units to
exercise.
The warrants have been recognised in
the financial statements based on the value at the date of signing
of the agreement. An initial entry has been made in contract assets
measured at fair value, but not subsequently remeasured with the
corresponding entry to equity. As the warrants represent non-cash
consideration payable to a customer under IFRS 15. The contract
asset, which effectively represents a deferred volume rebate, is
amortised to revenue based on when the units are supplied to
SpaceX. In this period under review, this represented a £901,000
charge to revenue.
The initial fair value of the
warrants at inception was £2,605,453, based on a fair value per
warrant of £0.11 and the total number of warrants expected to vest
over the 5-year vesting period. The directors have judged all of
the warrants will vest, otherwise SpaceX and Filtronic would not
have entered into the agreement.
The fair value of the warrants was
determined using the Black-Scholes Model valuation method using a
number of variables that require judgement including share price
volatility, discount to the bid price, the risk-free rate and the
expected life of the warrants. There are a number of variables that
require judgement within this model including the risk-free rate,
share price volatility, the vesting period and a bid price
discount.
11 Deferred income
|
6 months
|
6
months
|
Year
|
|
Ended
|
Ended
|
Ended
|
|
30 November
|
30
November
|
31
May
|
|
2024
|
2023
|
2024
|
|
£000
|
£000
|
£000
|
|
|
|
|
Contract liabilities
|
1,484
|
1,198
|
1,369
|
Capital grant
|
29
|
37
|
34
|
|
-----------
|
-----------
|
-----------
|
Total current deferred income
|
1,513
|
1,235
|
1,403
|
|
-----------
|
-----------
|
-----------
|
Contract
liabilities
|
-
|
392
|
-
|
Capital grant
|
116
|
145
|
132
|
|
-----------
|
-----------
|
----------
|
Total non-current deferred
income
|
116
|
537
|
132
|
|
-----------
|
-----------
|
-----------
|
Total deferred income
|
1,629
|
1,772
|
1,535
|
|
|
=======
|
=======
|
=======
|
|
|
|
| |
Contract liabilities are invoices
raised in advance of NRE work completed for customers that will be
recognised as income once the performance obligation of the
contract has been met. The majority of NRE contracts are invoiced
with a proportion of the contract value upfront which is recognised
as revenue, over time, across the life of contract at each
milestone based on the percentage of the overall contract value
achieved at that performance obligation.
12 Share Capital
|
|
|
|
|
|
Deferred shares of 10p
each
|
Ordinary shares of 0.1p
each
|
|
Number '000
|
Number '000
|
£000
|
|
|
|
|
At 30 November 2023
|
106,877
|
215,321
|
10,796
|
Exercise of employee share
options
|
-
|
1,800
|
2
|
|
------------
|
-------------
|
-------------
|
At 31 May 2024
|
106,877
|
217,121
|
10,798
|
Exercise of employee share
options
|
-
|
1,861
|
2
|
|
------------
|
------------
|
-------------
|
At
30 November 2024
|
106,877
|
218,982
|
10,800
|
|
========
|
========
|
========
|
|
|
|
|
|
|
| |
All shares are allotted, called up
and fully paid. Holders of the ordinary shares and entitled to
retrieve dividends when declared and are entitled to one vote per
share at meetings of the company.
Holders of the ordinary shares are
entitled to receive dividends when declared and are entitled to one
vote per share at meetings of the Company.
13 Share Premium
|
|
£000
|
|
|
|
At 30 November 2023
|
|
11,087
|
Exercise of employee share
options
|
|
126
|
|
|
-----------
|
At 31 May 2024
|
|
11,213
|
Exercise of employee share
options
|
|
139
|
|
|
-----------
|
At
30 November 2024
|
|
11,352
|
|
|
=======
|
14 Analysis of net
cash
|
1 June
2024
|
Cash
Flow
|
Other
movements
|
30 Nov 2024
|
|
£000
|
£000
|
£000
|
£000
|
|
|
|
|
|
Cash and cash equivalents
|
7,215
|
(8)
|
(3)
|
7,204
|
Lease liability - plant and
equipment
|
(1,990)
|
296
|
(363)
|
(2,057)
|
|
---------
|
---------
|
---------
|
---------
|
Net
cash when including all debt except property
leases
|
5,225
|
288
|
(366)
|
5,147
|
Lease liability - property
lease
|
(1,027)
|
139
|
-
|
(888)
|
|
---------
|
---------
|
---------
|
---------
|
Net
cash
|
4,198
|
427
|
(366)
|
4,259
|
|
======
|
======
|
======
|
======
|
Cash at bank earns interest at
floating rates based on daily bank deposit rates.
The Group entered into a new
financing arrangement in November 2024 with Santander UK plc. This
included the operational banking facilities and successful
attainment of a committed £5.0m Revolving Credit Facility ("RCF")
for three years from November 2024. Consequently, the invoice
discounting facilities with Barclays Bank and Wells Fargo have been
closed.
There were no drawings on the RCF
facility at 30 November 2024 (31 May 2024: undrawn).
15 Restatement of financial
statements
Restatements have been made to some
of the financial statements for the period ended 31 May 2024. This
impacted the Consolidated Statement of Financial Position and
Statement of Changes In Equity but there have been no amendments to
the income statement or cash flow statement.
The share warrants have been
restated in line with the IAS 32 accounting standard which requires
the fair value of share warrants to be accounted for as a contract
asset with a corresponding entry to equity or financial liability.
The director's judged this to be accounted for as equity. IAS 32
requires for this to be accounted at the time the warrant agreement
was signed. Consequently, the contract asset in FY2024 increased by
£2.6m, prior to amortisation, and equity in the share warrant
reserve increased by £2.6m.
|
31
May
|
|
31
May
|
|
|
2024
|
|
2024
|
|
(Audited)
|
Correction
|
(Audited*)
|
|
£000
|
£000
|
£000
|
Non-current assets
|
|
|
|
|
Contract assets
|
-
|
1,302
|
1,302
|
|
|
----------
|
----------
|
----------
|
|
|
8,227
|
1,302
|
9,529
|
|
|
----------
|
----------
|
----------
|
|
Current assets
|
|
|
|
|
Contract assets
|
-
|
1,303
|
1,303
|
|
|
----------
|
----------
|
----------
|
|
|
17,038
|
1,303
|
18,341
|
|
|
----------
|
----------
|
----------
|
|
|
|
|
|
|
|
----------
|
----------
|
----------
|
|
Total assets
|
25,265
|
2,605
|
27,870
|
|
|
----------
|
----------
|
----------
|
|
|
----------
|
----------
|
----------
|
|
Net
assets
|
14,815
|
2,605
|
17,420
|
|
|
======
|
======
|
======
|
|
Equity
|
|
|
|
|
Share warrant reserve
|
-
|
2,605
|
2,605
|
|
|
----------
|
----------
|
----------
|
|
Total equity
|
14,815
|
2,605
|
17,420
|
|
|
======
|
======
|
======
|
|
|
|
|
|
| |
* Certain prior period figures are
restated, please refer to note 15 for further
information.